We are here to assist you.
Health Advisor
+91-8877772277Available 7 days a week
10:00 AM – 6:00 PM to support you with urgent concerns and guide you toward the right care.
Explore comprehensive strategies for reducing protein in IgA nephropathy. This guide covers symptoms, diagnosis, lifestyle changes, medications like ACE inhibitors, ARBs, SGLT2 inhibitors, and emerging therapies to protect kidney function and improve outcomes.
IgA nephropathy, also known as Berger's disease, is the most common primary glomerular disease worldwide, affecting millions. It occurs when immunoglobulin A (IgA) deposits build up in the glomeruli, the tiny filters within your kidneys. These deposits cause inflammation and damage, leading to a range of symptoms, with one of the most critical being proteinuria – the presence of excessive protein in the urine. Proteinuria is not merely a symptom; it's a significant indicator of kidney damage and a strong predictor of progression to end-stage renal disease (ESRD). Therefore, effectively reducing proteinuria is a cornerstone of IgA nephropathy management, crucial for preserving kidney function and improving long-term outcomes. This comprehensive guide will delve into the intricacies of IgA nephropathy, its diagnosis, and, most importantly, the multifaceted strategies available to reduce proteinuria and safeguard your kidney health.
IgA nephropathy is an autoimmune condition where the body's immune system mistakenly attacks its own kidney tissue. Specifically, abnormally formed IgA antibodies accumulate in the glomeruli. While the exact trigger for this autoimmune response is not fully understood, a combination of genetic predisposition and environmental factors is believed to play a role. The inflammation caused by these IgA deposits impairs the kidney's ability to filter waste products from the blood effectively, leading to various complications, including proteinuria, hematuria (blood in urine), and hypertension.
Normally, your kidneys filter waste products while retaining essential proteins in your blood. When the glomeruli are damaged, they become leaky, allowing proteins like albumin to escape into the urine. The more protein present in the urine, the more severe the kidney damage is considered. Persistent and significant proteinuria accelerates the decline in kidney function, increasing the risk of developing chronic kidney disease (CKD) and eventually ESRD, which requires dialysis or kidney transplantation. Therefore, managing and reducing proteinuria is a primary therapeutic goal.
IgA nephropathy often progresses silently for years, with many individuals experiencing no noticeable symptoms in the early stages. When symptoms do appear, they can vary widely in severity and presentation. Recognizing these signs is crucial for early diagnosis and intervention.
It's important to note that these symptoms are not exclusive to IgA nephropathy and can be indicative of other kidney or systemic conditions. Therefore, prompt medical evaluation is essential for accurate diagnosis.
While the precise cause of IgA nephropathy remains elusive, it is understood to be an autoimmune condition with a complex interplay of genetic and environmental factors. It is not caused by specific lifestyle choices, but lifestyle can influence its progression.
Multiple vasopressors are kept in OT to quickly manage sudden hypotension with the most suitable drug for each clinical condition.
April 16, 2026
A GA drug list is a pre-surgery checklist of essential anaesthetic drugs, ensuring safety and readiness in the operation theatre.
April 16, 2026
April 15, 2026